Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 StarpharmaKodiak SciencesNeptune Wellness SolutionsOxford BioMedicaResverlogix
SymbolN/ANYSE:KODTSE:NEPTLON:OXBTSE:RVX
Price Information
Current PriceN/A$11.28C$5.52GBX 636C$2.83
52 Week RangeN/ABuyN/ABuyBuy
Analyst Ratings
Consensus RecommendationN/ABuyN/ABuyBuy
Consensus Price TargetN/A$19.1250N/AN/AN/A
% Upside from Price TargetN/A69.55% upsideN/AN/AN/A
Trade Information
Market Cap$451.61 million$416.58 millionC$510.44 million£488.24 millionC$591.91 million
BetaN/AN/AN/AN/AN/A
Average Volume544,824113,127326,6076,890,00083,599
Sales & Book Value
Annual Revenue$4.37 millionN/AC$24.44 million£66.78 millionN/A
Price / Sales0.00N/A20.887.31N/A
CashflowN/AN/AC$0.11 per shareGBX 48.12 per shareC$0.04 per share
Price / Cash10.08N/A50.0813.2274.00
Book ValueA$0.13 per shareN/AC$0.86 per shareGBX 52.60 per shareC($1.08) per share
Price / Book0.00N/A6.400.12N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSA($0.03)N/AC($0.29)GBX 10.90C($0.87)
Trailing P/E RatioN/A0.00N/A58.35N/A
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.08%N/A5.03%118.46%N/A
Current Ratio12.11%N/A1.23%2.44%0.12%
Quick Ratio12.11%N/A0.79%2.26%0.10%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
EmployeesN/AN/A58432N/A
Shares Outstanding371.69 million36.93 million92.47 million76.77 million209.15 million
Next Earnings DateN/A11/15/2019 (Estimated)11/11/2019 (Estimated)9/4/2019 (Estimated)9/13/2019 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable
 StarpharmaKodiak SciencesNeptune Wellness SolutionsOxford BioMedicaResverlogix

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel